PLRZ

Polyrizon Ltd. (PLRZ) develops and manufactures advanced polymer-based filtration and separation technologies for industrial and medical applications. Headquartered in Israel, the company specializes in creating synthetic polymers that selectively bind and remove targeted substances from liquids, including blood and industrial fluids. Polyrizon's core product portfolio includes its proprietary Seraph® 100 Microbind® Affinity Blood Filter, designed to remove pathogens from blood during sepsis treatment, and industrial filtration systems for water purification and chemical processing. The company operates through two primary business segments: medical devices and industrial applications. Polyrizon's Seraph 100 device has received CE Mark approval in Europe and is used in critical care settings across multiple countries. The technology platform is based on heparin-coated beads that attract and capture bacteria, viruses, and toxins through surface adsorption. The company maintains research and development facilities in Israel and has established distribution partnerships in Europe, Asia, and other international markets. Recent developments include expanded clinical adoption of the Seraph filter during health emergencies and ongoing regulatory efforts to broaden market access. Polyrizon collaborates with medical institutions and industrial partners to validate applications of its polymer technology across diverse filtration challenges.